Cadila Healthcare submits press release

21 Nov 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated November 21, 2019 titled ‘Zydus receives final approvals from the USFDA for Isosorbide Dinitrate Tablets and Desonide Cream’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

890.20 -6.40 (-0.71%)
29-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.55
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2122.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×